Tag: CBT > Cannabis Schedule: Page 7

Cannabis Rescheduling

‘Rescheduling is Not Enough,’ And Other Reactions to HHS Recommendation on Cannabis

Cannabis industry responds with cautious optimism to the Department of Health and Human Services' call to reschedule the plant, noting the significance of the announcement but also the potential limitations of the move.

September 5, 2023

Cannabis Rescheduling

US Health and Human Services Department Recommends Cannabis Reclassified to Schedule III

The move from Schedule I to Schedule III would provide that cannabis has a federally accepted medical use, but the decision now goes to the DEA.

August 30, 2023

Interviews & Opinion

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

August 29, 2023

Legislation and Regulation

Boston … ‘280E THC’ Party? MariMed Takes it Back to 1773

The Massachusetts-based multistate cannabis operator protested unfair cannabis industry tax laws that have hurt businesses and workers alike.

July 13, 2023

Cannabis Rescheduling

New Coalition Launches Campaign in Support of Cannabis Scheduling Reform

As the Biden Administration actively reviews the classification of cannabis under the Controlled Substances Act, a diverse group of cannabis companies and organizations is partnering with scientific and legal experts to launch the Coalition for Cannabis Scheduling Reform.

June 6, 2023

The Last Word

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

March 13, 2023

Cannabis Rescheduling

US Representative Reintroduces Legislation to Reschedule Cannabis

Rep. Greg Steube has reintroduced the Marijuana 1-to-3 Act, which would reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

February 1, 2023

Hemp Research

Risky Research

January 5, 2023

Legislation and Regulation

US House Members Release Memo on Benefits of Cannabis Decriminalization, Descheduling, Propose Reforms

The U.S. House Oversight Committee’s Subcommittee on Civil Rights and Civil Liberties released the joint memo ahead of a Nov. 15 hearing on cannabis.

November 14, 2022

Legislation and Regulation

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

November 7, 2022

2022 Election and Cannabis

Will Cannabis Policy Change?

Past reviews of cannabis’s Schedule I classification in the Controlled Substances Act—the most recent of which took five years and ended in 2016—have never moved the needle with the Drug Enforcement Agency. Many wonder if this time will be different with the directive coming from the president.

October 26, 2022

Legislation and Regulation

Biden's Order to Review Cannabis 'Truly Historic,' But What's at Stake?

Many industry experts agree removing cannabis from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster' for the state-legal industry.

October 26, 2022